Ratings
0
Nobody has rated this yet. Be the first!
Works
3
Mechanisms of tamoxifen resistance: increased estrogen receptor-HER2/neu cross-talk in ER/HER2-positive breast cancer
Shallow WGS of individual CTCs identifies actionable targets for informing treatment decisions in metastatic breast cancer
Differential oestrogen receptor binding is associated with clinical outcome in breast cancer
